Related Experiment Video
Updated: May 2, 2026

Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility
Published on: March 11, 2022
ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration
Joanne Chia1, Keit Min Tham, David James Gill
1Institute of Molecular and Cell Biology, Singapore, Singapore.
Abstract:
ER O-glycosylation can be induced through relocalisation GalNAc-Transferases from the Golgi. This process markedly stimulates cell migration and is constitutively activated in more than 60% of breast carcinomas. How this activation is achieved remains unclear. Here, we screened 948 signalling genes using RNAi and imaging. We identified 12 negative regulators of O-glycosylation that all control GalNAc-T sub-cellular localisation. ERK8, an atypical MAPK with high basal kinase activity, is a strong hit and is partially localised at the Golgi. Its inhibition induces the relocation of GalNAc-Ts, but not of KDEL receptors, revealing the existence of two separate COPI-dependent pathways. ERK8 down-regulation, in turn, activates cell motility. In human breast and lung carcinomas, ERK8 expression is reduced while ER O-glycosylation initiation is hyperactivated. In sum, ERK8 appears as a constitutive brake on GalNAc-T relocalisation, and the loss of its expression could drive cancer aggressivity through increased cell motility. DOI: http://dx.doi.org/10.7554/eLife.01828.001.
Insights
Loss of ERK8 protein expression promotes cancer cell migration by enabling ER O-glycosylation. This pathway is hyperactivated in breast and lung carcinomas, suggesting ERK8 as a brake on cancer aggressiveness.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Endoplasmic reticulum (ER) O-glycosylation is regulated by the localization of GalNAc-Transferases (GalNAc-Ts).
- Aberrant O-glycosylation is linked to increased cell migration and is a hallmark of many breast carcinomas.
- The precise mechanisms controlling GalNAc-T localization and O-glycosylation in cancer remain largely unknown.
Purpose of the Study:
- To identify signaling pathways regulating the sub-cellular localization of GalNAc-Ts.
- To investigate the role of ERK8 in controlling ER O-glycosylation and cell motility.
- To determine the clinical relevance of ERK8 expression in human carcinomas.
Main Methods:
- Genome-wide RNA interference (RNAi) screen of 948 signaling genes coupled with high-content imaging.
- Analysis of GalNAc-T and KDEL receptor localization.
- Western blotting to assess protein expression levels.
- Immunofluorescence microscopy to determine protein localization.
Main Results:
- A screen identified 12 negative regulators of O-glycosylation, all affecting GalNAc-T localization.
- ERK8, an atypical mitogen-activated protein kinase (MAPK), was identified as a key regulator.
- ERK8 inhibition caused GalNAc-T relocalization via a COPI-dependent pathway, distinct from KDEL receptor trafficking.
- ERK8 downregulation increased cell motility and was associated with reduced ERK8 expression and hyperactivated O-glycosylation in human breast and lung carcinomas.
Conclusions:
- ERK8 acts as a constitutive brake on GalNAc-T relocalization and ER O-glycosylation.
- Loss of ERK8 expression in cancer may drive increased cell migration and aggressiveness.
- Targeting the ERK8-GalNAc-T axis could offer new therapeutic strategies for carcinomas.
Related Concept Videos
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Negative Regulator Molecules
Global Regulatory Systems
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

